Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Sees Large Growth in Short Interest

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 28,100 shares, an increase of 5.2% from the November 15th total of 26,700 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Wall Street Analyst Weigh In

Separately, HC Wainwright upgraded Basilea Pharmaceutica to a “strong-buy” rating in a research report on Monday, September 23rd.

Basilea Pharmaceutica Stock Performance

OTCMKTS BPMUF opened at $52.83 on Tuesday. The stock has a 50 day moving average price of $52.74 and a 200-day moving average price of $50.37. Basilea Pharmaceutica has a one year low of $38.60 and a one year high of $52.83.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.